Blogroll

Sony Corp on Thursday said it would make its cash-cow image sensors smarter to broaden their application, as the Japanese electronics maker seeks to reduce reliance on a saturated smartphone market.

Skin cells reprogrammed to produce the neurotransmitter dopamine and inserted deep into the brain of a 69-year-old man with Parkinson's disease have allowed him to tie his shoes again and resume swimming and biking, researchers reported in The New England Journal of Medicine on Wednesday.

Chipmaker AT&S has kept core profit stable so far in its financial first quarter, it said on Thursday after reporting a 22% decline for the full year on investment to expand the businesss.

Japan has begun treating severely ill COVID-19 patients with Gilead Sciences Inc's COVID-19 remdesivir drug, a health ministry official said, just days after giving the drug emergency approval as it seeks to curb the coronavirus outbreak.

China's foreign ministry, asked about China-linked hackers breaking into U.S. COVID-19 research, said China opposed what it called slander from the United States.

Australia says its purchase of 10 million coronavirus test kits from Chinese genomics company BGI will not risk patient privacy, as researchers hope for greater price competition in a biotech market dominated by a U.S rival.

Over a third of patients treated for COVID-19 in a large New York medical system developed acute kidney injury, and nearly 15% required dialysis, U.S. researchers reported on Thursday.

Finnish telecom equipment maker Nokia said on Thursday it would buy back 150 million euros ($162 million) of its March 2021 notes as it restructures its finances.

Britain is in talks with Swiss drugmaker Roche Holding AG on rolling out an accurate COVID-19 antibody test that it said could be a 'game changer' on getting the world's fifth largest economy back to work.

Shares in Norway's Pexip Holding soared by 54% in early trade on Thursday as the video conferencing company made its stock market debut after an initial public offering (IPO) that was more than 12 times oversubscribed.

A study led by the Pasteur Institute says a mere 4.4% of the French population - or 2.8 million people - have been infected by the novel coronavirus, much higher than the official count of cases but way too low to achieve so-called "herd immunity".

Tougher scrutiny of foreign investment in India has soured the plans of China's smartphone manufacturers seeking to expand beyond selling hardware for a bigger share of the South Asian country's competitive financial services market.

Jamaica-based mobile phone carrier Digicel Group denied an Australian newspaper report on Thursday and said there is "no basis whatsoever" that it would sell its Pacific unit to state-owned China Mobile Ltd .

Printed circuit boards maker AT&S said on Thursday that core profit and revenue in its current first quarter were on the previous year's level after posting a 22% decline for the financial year due to investments in its expansion.

French healthcare company Sanofi said on Thursday that the U.S. Food & Drug Administration (FDA) regulator had granted a priority review for Sanofi's sutimlimab product, which treats hemolysis in adults suffering from cold agglutinin disease.

A group of privacy advocacy organizations is filing a complaint with the Federal Trade Commission on Thursday alleging that the popular app TikTok violated a consent decree and a law protecting children's privacy online.

The number of confirmed coronavirus cases in Germany rose 933 to stand at 172,239, data from the Robert Koch Institute (RKI) for infectious diseases showed on Thursday.

High demand for video games during COVID-19 lockdowns buoyed Tencent Holdings' first-quarter revenue and profits, with blockbuster games PlayerUnknown's Battlegrounds Mobile and Honor of Kings helping it beat forecasts.

The coronavirus that causes COVID-19 could become endemic like HIV, the World Health Organization said on Wednesday, warning against any attempt to predict how long it would keep circulating and calling for a "massive effort" to counter it.

President Donald Trump is expected to tap a former GlaxoSmithKline executive and a U.S. general to spearhead the government's effort at developing a coronavirus vaccine on an accelerated schedule, officially called "Operation Warp Speed," an administration official said on Wednesday.